What We Do Not Know We lack peer reviewed data defining systemic exposure thresholds, tissue distribution, immunogenicity rates, potential peptide related impurities impact, chronic dosing safety, interaction with existing pathologic angiogenesis (e.g
We also follow strict manufacturing standards, with state-of-the-art facilities and quality control processes in place to ensure that our products meet the highest levels of safety and quality
Periodic breaks from peptide use enable baseline assessment and prevent potential desensitization, though evidence for desensitization with these peptides remains limited
In laboratory and pre-clinical research settings, the Wolverine Stack is studied for its dual-phase coverage of the tissue repair cascade with BPC-157 addressing the vascular, fibroblast, and ECM phases of repair, and TB-500 addressing the cellular migration, cytoskeletal, and stem cell mobilisation phases